| Line Item | 2025-09-30 | Y/Y |
|---|---|---|
| Revenue | $3.09B | +9.7% |
| Cost of Revenue | $574.0M | +2.9% |
| Gross Profit | $2.51B | +11.3% |
| R&D Expense | $539.8M | +10.1% |
| SG&A Expense | $322.3M | +19.9% |
| Operating Income | $765.9M | +16.3% |
| Pre-tax Income | $808.3M | +16.2% |
| Income Tax | $116.0M | -9.9% |
| Net Income | $692.4M |
| Line Item | 2025-09-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.34B | +25.1% |
| Short-term Investments | $0 | — |
| Accounts Receivable | $414.4M | +6.5% |
| Inventory | $77.2M | +1.1% |
| Current Assets | $2.52B | +19.4% |
| Total Assets | $6.32B | +12.6% |
| Current Liabilities | $1.61B | +8.3% |
| Line Item | 2025-09-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | $949.7M | +19.8% |
| Capital Expenditures | $43.3M | +42.2% |
| Investing Cash Flow | -$219.5M | -270.7% |
| Financing Cash Flow | -$464.8M | -1.7% |
| Free Cash Flow | $906.4M | +18.9% |
| +22.2% |
| EPS (Basic) | $11.96 | +23.9% |
| EPS (Diluted) | $11.80 | +23.6% |
| Stockholders' Equity |
| $3.59B |
| +14.8% |